Title: The $800 Million Pill
Description: "Drug companies insist that [prescription drug] prices reflect the millions they invest in research and development ... Merrill Goozner contends that American taxpayers are in fact footing the bill twice: once by supporting government-funded research and again by paying high prices for prescription drugs. Goozner demonstrates that almost all of the important and life-saving new drugs of the past quarter-century actually originated from research at taxpayer-funded universities and the National Institutes of Health ... [Goozner] suggests ways that the government's role in testing new medicines could be expanded to eliminate private-sector waste driving up the cost of existing drugs--p. [2] of jacket.
Subjects: Drug Industry, Médicaments, Forschungsfinanzierung, Prescription pricing, Éducation, Drugs, E ducation, Arzneimittelpreis, Arzneimittelforschung, Industrie pharmaceutique, Me dicaments, Prices, Öffentliche Förderung, Pharmazeutische Industrie, Forschungsausgaben, O ffentliche Fo rderung, Economics, Staatliche Einrichtung, Pharmaceutical industry, Consumer education, Consommateurs, Prix, Drug Therapy, Biomedical Research, Drug development, Drugs, prices